key: cord-0858689-jqjics10
authors: Shim, Sang-Mu; Kim, Jun-Won; Jung, Sunhee; Jung, Yujung; Woo, Hye-Min; Yang, Jeong-Sun; Kim, Kyung-Chang; Lee, Joo-Yeon
title: Persistence of the neutralising antibody response after SARS-CoV-2 infection
date: 2021-12-23
journal: Clin Microbiol Infect
DOI: 10.1016/j.cmi.2021.12.012
sha: 9b7c57987d1b370e779231fe873d6a4e7e088534
doc_id: 858689
cord_uid: jqjics10

OBJECTIVE: Neutralising antibodies are one of the factors to measure individual’s immune status for control of infectious diseases. We aimed to confirm the persistence of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) neutralising antibody levels in patients who had recovered from coronavirus disease (COVID-19). METHODS: Plasma donors in South Korea who had completely recovered from SARS-CoV-2 infection had follow-up testing to determine the persistence of neutralising antibodies using a plaque-reduction neutralisation test and ELISA. RESULTS: Of the 111 participants (20–29 years, 37/111 [33.3%]; 30–39 years, 17/111 [15.3%]; 40–49 years, 23/111 [20.7%]; 50–59, 21/111 [18.9%]; 60–65 years, 13/111 [11.7%]; male, 43/111 [38.7%]; female, 68/111 [61.3%]), 66.1% still had neutralising antibodies approximately 9 months(range 255 to 302 days) after confirmation of the diagnosis. CONCLUSIONS: In this study, we analyzed the titre of neutralising antibodies associated with predicting immune status in individuals with natural infection. Information about the persistence and change in levels of neutralising antibodies against SARS-CoV-2 can be utilised to provide evidence for developing vaccination schedules for individuals with previous infection.

persistence of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) 27 neutralising antibody levels in patients who had recovered from coronavirus 28 disease (COVID-19). 

It is important to confirm the change of antibody levels and the persistence of 48 neutralising antibodies in individuals who recover from natural infections in 49 order to determine their infection status, predict prevention of reinfection, and 50 establish vaccination policies in the context of pandemics [1, 2] . In this study, we Table 2 ). The Spearman correlation (r 118 value) of the total antibodies measured using the PRNT method and the nAb 119 using ELISA was 0.450 (Fig. 1D) . In contrast to the nAb, the total antibodies 120 were maintained for 9 months in 93.6% (102/111) of participants 121 (Supplementary Table 3) . None of the participants tested positive for SARS- shown nAb measusred using ELISA, which may replace the PRNT method even 

Serological 185 assays for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)

SARS-CoV-2 neutralizing antibodies in patients with 190 varying severity of acute COVID-19 illness

Analytical and clinical performances of five immunoassays for the detection of 194

SARS-CoV-2 antibodies in comparison with neutralization activity

Severe acute respiratory syndrome coronavirus 2-specific antibody 198 responses in coronavirus disease patients

A high-throughput neutralizing antibody assay for COVID-19 202 diagnosis and vaccine evaluation

ACE2-spike protein-protein interaction

Dynamics of SARS-CoV-2 neutralizing antibody responses and duration of 215 immunity: a longitudinal study

Antibody persistence in the first 6 months following 219

SARS-CoV-2 infection among hospital workers: a prospective longitudinal 220 study